Aurobindo Pharma

AUROPHARMA29 Apr 2024

Pharmaceuticals

₹

+20.50 (+1.81%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Aurobindo Pharma

Aurobindo Pharma

Pharmaceuticals

AUROPHARMA29 Apr 2024

₹

+20.50 (+1.81%)

OverviewFundamentalsFutures Options

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
03-Nov-2010	S	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2010, inter alia, has approved the following: The Board has approved the sub-division of equity shares of the face value of Rs. 5/- each in the Company into equity shares of the face value of Re. 1/- each. The sub-division would be subject to the approval of the shareholders and such other approvals as may be necessary. Aurobindo Pharma Ltd has informed BSE that the shareholders at the Extraordinary General Meeting (EGM) of the Company held on December 23, 2010, have approved the sub-division of one equity share of the face value of Rs. 5/-each in the Company into five equity shares of the face value of Rs. 1/- each. (As Per BSE Announcement Website Dated on 23/12/2010) SUB. :- Sub Division of equity shares of Aurobindo Pharma Limited (Scrip Code 524804) Trading Members of the Exchange are hereby informed that, Aurobindo Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Aurobindo Pharma Limited (524804 & 624804) RECORD DATE 11.02.2011 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 10/02/2011 DR- 222/2010- 2011 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 10/02/2011. ii. ISIN No. INE 406 A01029 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 10/02/2011. iii. The new ISIN Number for Re.1- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 04.01.2011)	11-Feb-2011
07-Oct-2003	S	Sub Division of existing equity shares from every ONE existing equity share of Rs.10/- each into TWO equity shares of Re.5/- each. REDUCED PAID-UP VALUE - Rs.5/- REDUCED PAID-UP VALUE W.E.F. - 23/10/2003	31-Oct-2003
10-Feb-2024	D	Board of Directors in their meeting held today, February 10, 2024, approved the payment of Second Dividend of 150% i.e. Rs.1.50 per shares of Re.1 each.	20-Feb-2024
09-Nov-2023	D	The Board of Directors of the Company at its meeting held today, November 9, 2023, has inter alia, transacted the following items of business: Approved first interim dividend of 300% i.e., Rs.3.00 (Rupees three only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed November 20, 2023 as the record date for the purpose of payment of interim dividend for the financial year 2023-24 and the said interim dividend will be paid on or before December 4, 2023.	20-Nov-2023
09-Feb-2023	D	The Board of Directors of the Company at its meeting held today, February 9, 2023, has inter alia, transacted the following items of business: Approved first interim dividend of 300% i.e. Rs.3.00 (Rupees three only) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed February 17, 2023 as the record date for the purpose of payment of interim dividend for the financial year 2022-23. The interim dividend will be paid on or before March 3, 2023.	17-Feb-2023
30-May-2022	D	The Board of Directors of the Company at its meeting held today, May 30, 2022, has inter alia, approved fourth interim dividend of 450% i.e. Rs.4.50 (Rupees four and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company. The Company has already fixed June 7, 2022 as the record date for the purpose of payment of fourth interim dividend for the financial year 2021-22. The interim dividend will be paid on or before June 15, 2022.	06-Jun-2022
09-Feb-2022	D	The Board of Directors of the Company at its meeting held today, February 9, 2022, has, inter alia, considered and approved:- Third Interim Dividend @ 150% i.e. Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2021-22. The Company has fixed February 21, 2022 as the Record Date for the purpose of payment of Third Interim Dividend and the same will be paid on or before March 4, 2022.	18-Feb-2022
08-Nov-2021	D	The Board of Directors of the Company at its meeting held today, November 8, 2021, has, inter alia, considered and approved:- Second Interim Dividend @ 150% i.e Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2021-22. The Company has fixed November 18, 2021 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before November 30, 2021. We also enclose a copy of the Press Release on Un-audited Financial Results of the Company for the Second Quarter and half year ended September 30, 2021.	17-Nov-2021
12-Aug-2021	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2021, inter alia, has considered and approved an Interim Dividend @ 150% i.e. Rs. 1.50 (Rupee one and paise fifty) per equity share of Re. 1/- each on the equity share capital of the Company for the Financial Year 2021-22 and the same will be paid on or before September 07, 2021.	27-Aug-2021
10-Feb-2021	D	The Board of Directors of the Company at its meeting held today, February 10, 2021, has, inter alia, considered and approved: Third Interim Dividend @ 150% i.e Rs.1.50 (Rupee one and paise fifty) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. The Company has fixed February 23, 2021 as the Record Date for the purpose of payment of Third Interim Dividend and the same will be paid on or before March 4, 2021. The Board meeting commenced at 4.00 p.m. and concluded at 6.40 p.m.	22-Feb-2021
11-Nov-2020	D	The Board of Directors of the Company at its meeting held today, November 11, 2020, has, inter alia, considered and approved:- a Second Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. The Company has fixed November 24, 2020 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before December 4, 2020.	23-Nov-2020
12-Aug-2020	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2020, inter alia, has approved an Interim Dividend @ 125% i.e. Rs. 1.25 (Rupee one and paise twenty five) per equity share of Re. 1/- each on the equity share capital of the Company for the Financial Year 2020-21.	21-Aug-2020
06-Feb-2020	D	The Board of Directors of the Company at its meeting held today, February 6, 2020, has inter alia, approved a Second Interim Dividend @ 175% i.e Rs.1.75 (Rupee one and paise seventy five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. The Company has fixed February 18, 2020 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before March 2, 2020.	17-Feb-2020
12-Nov-2019	D	The Board of Directors of the Company at its meeting held today,November 12,2019,has interalia, transacted the following businesses: Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2019-20. The Company has fixed November 23,2019 as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before December 4, 2019. We enclose a copy of the Press Release on Unaudited Financial Results of the Company for the second quarter and half year ended September 30,2019.	21-Nov-2019
07-Feb-2019	D	The Board of Directors of the Company at its meeting held today, February 7, 2019, has inter alia, approved a Second Interim Dividend @125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2018-19. The Company has fixed February 19, 2019 as the Record Date for the purpose of payment of Second Interim Dividend and the same will be paid on or before February 28, 2019.	15-Feb-2019
12-Nov-2018	D	The Board of Directors of the Company at its meeting held on 12th November, 2018 has inter alia, approved Interim Dividend @125% i.e Rs.1.25/- (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2018-19. The Company has fixed 22nd November, 2018 as the Record Date for the purpose of payment of Interim Dividend and the same will be paid on or before 30th November, 2018.	20-Nov-2018
07-Feb-2018	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2018, inter alia, has approved second interim dividend @100% i.e. Re.1 (Rupee One only) per equity share of Re.1 (Rupee One only) for the year 2017-18.	20-Feb-2018
09-Nov-2017	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09, 2017, inter alia, has considered & approved interim dividend @150% i.e. Rs. 1.50 (Rupee One & paise fifty only) per equity shares of Re 1/- each on the equity share capital of the Company for the year 2017-18. The Interim Dividend will be paid on or before November 30, 2017.	21-Nov-2017
30-May-2017	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2017, inter alia, has considered and approved second interim dividend of 125% i.e. Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17. The Company has paid first interim dividend of 125% i.e. Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1 each in the month of December 2016 on the equity share capital of the Company for the financial year 2016-17. Thus the total dividend, including the second interim dividend for the financial year 2016-17 will aggregate to 250% i.e. Rs.2.50 (Rupee two and paise fifty only) per equity share of Re.1/- each on the equity share capital of the Company. The Board of Directors has not recommended any final dividend for the financial year 2016-17. The Board of Directors of the Company at its meeting held on 29th May 2017 has inter-alia considered and approved second interim dividend of 125% i.e Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17. The Company has fixed 9th June 2017 as the Record Date for the purpose of payment of Second Interim Dividend for the financial year 2016-17. The Interim Dividend will be paid on or before 21st June 2017. The Board of Directors has not recommended any final dividend for the financial year 2016-17.	08-Jun-2017
14-Nov-2016	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 14, 2016, inter alia, has approved an interim dividend @125% i.e. Re. 1.25 (One Rupee and Paise twenty five only) per equity share of Re. 1/- (Rupees One only) for the year 2016-17. The Board of Directors of the Company at its meeting held on 29th May 2017 has inter-alia considered and approved second interim dividend of 125% i.e Rs.1.25 (Rupee one and paise twenty five only) per equity share of Re.1/- each on the equity share capital of the Company for the financial year 2016-17. The Company has fixed 9th June 2017 as the Record Date for the purpose of payment of Second Interim Dividend for the financial year 2016-17. The Interim Dividend will be paid on or before 21st June 2017. The Board of Directors has not recommended any final dividend for the financial year 2016-17. (As per BSE Announcement date on 29/05/2017)	24-Nov-2016
30-May-2016	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has considered and approved fourth interim dividend of 70% (Re. 0.70 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2015-16. The Company has paid first interim dividend of 50% (Re.0.50 per equity share of Re.1 each) in the month of September 2015, second interim dividend of 60% (Re. 0.60 per equity share of Re. 1 each) in the month of November, 2015 and third interim dividend of 70% (Re. 0.70 per equity share of Re. 1 each) in the month of March, 2016 on the equity share capital of the Company for the year 2015-16. Thus the total dividend, including the fourth interim dividend for the year ended March 31, 2016 will aggregate to 250% (Rs. 2.50 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2015-16. The Board of Directors does not recommend any further dividend for the year 2015-16.	09-Jun-2016
09-Feb-2016	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 09, 2016, inter alia, has considered and approved third interim dividend of 70% i.e. Re. 0.70 (Paise seventy only) per equity share of Re. 1/- each for the year 2015-16. The Company had paid first interim dividend of 50% i.e., Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each and second interim dividend of 60% i.e., Re. 0.60 (Paise sixty only) per equity share of Re. 1/- each for the year 2015-16 in September 2015 and November 2015 respectively. The Third Interim Dividend will be paid on or before March 01, 2016.	18-Feb-2016
06-Nov-2015	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 06, 2015, inter alia, has considered and approved second interim dividend of 60% i.e. Re. 0.60 (Paise sixty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16. The Company in the month of September 2015 had paid first interim dividend of 50% i.e. Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16.	19-Nov-2015
12-Aug-2015	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, inter alia, has considered and approved interim dividend of 50% i.e. Re. 0.50 (Paise fifty only) per equity share of Re. 1/- each on the equity share capital of the Company for the year 2015-16. The Interim Dividend will be paid on or before 4th September, 2015. With reference to the earlier annoucement dated May 28, 2015, regarding the Register of Members and Share Transfer Books of the Company is being closed from August 25, 2015 to August 27, 2015 (both days inclusive) for the purpose of 28th Annual General Meeting of the Company. Aurobindo Pharma Ltd has now informed BSE that the aforesaid book closure dates will also be considered to determine the entitlement of the shareholders to the interim dividend of 50% i.e Re. 0.50 (Raise fifty only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2015-16 as approved by the Board on August 12, 2015. (As Per BSE Announcement Dated on 12/08/2015)	21-Aug-2015
28-May-2015	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, has considered and approved third interim dividend of 100% (Re.1 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2014-15. The Board of directors do not recommend any further dividend for the year 2014-15.	08-Jun-2015
05-Feb-2015	D	Aurobindo Pharma Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 04, 2015 has inter-alia considered and approved second interim dividend of 200% i.e Rs.2.00 (Rupees two only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2014-15. The Company in the month of September 2014 had paid first interim dividend of 150% i.e Rs.1.50 (Rupee one and paise fifty only) per equity share of Re.1/- each on the equity share capital of the Company for the year 2014-15.	16-Feb-2015
07-Aug-2014	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 07, 2014, inter alia, has considered & approved Interim dividend of 150% i.e. Rs.1.50/- (Rupee one and paise fifty only) per share of Re. 1/- each on the equity share capital of the Company for the year 2014-15. The Interim Dividend will be paid on or before September 05, 2014.	13-Aug-2014
30-May-2014	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has approved a second interim dividend @175% on the equity share capital of the Company i.e. Rs.1.75/- per share. This is in addition to interim dividend @125% on equity share capital of the Company i.e. Rs. 1.25 per share paid in November, 2013. The Board of directors do not recommend any further dividend for the year 2013-14,	11-Jun-2014
08-Nov-2013	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 07, 2013, inter alia, has approved payment of an Interim Dividend @ 125% i.e., Rs.1.25 (Rupee one and paise twenty five only) per Equity Share of Re. 1/- (Rupee one only) each to the members of the Company for the Financial Year 2013-14. The Interim Dividend will be paid on or after November 27, 2013	19-Nov-2013
30-May-2013	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has considered and approved the following : - The final dividend at 50% (Re.0.50 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2012-13 has been recommended, subject to approval of members. The Company in the month of February 2013 has paid an interim dividend of 100% (Re. 1.00 per equity share of Re. 1/- each) on the equity share capital of the Company for the year 2012-13.	30-Jul-2013
07-Feb-2013	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2013, inter alia, has approved an interim dividend @100% i.e. Re.1/- (Rupees One Only) per equity share of Re. 1 (Rupees One only) for the year 2012-13.	18-Feb-2013
30-May-2012	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2012, inter alia, has recommended final dividend @ 100% on the equity share capital of the Company i.e. Re. 1/- per share subject to approval of members.	30-Jul-2012
09-May-2011	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2011, inter alia, has recommended final dividend at 100% (Re. 1.00 per share of Re. 1/- each) on the equity share capital of the Company for the year 2010-2011, subject to approval of members. The Company in the month of November, 2010 has paid an interim dividend of 100% (Rs. 5.00 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2010-2011.	20-Jul-2011
03-Nov-2010	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2010, inter alia, has approved the following: The Board has approved an interim dividend of 100% i.e. Rs. 5/- per equity share of Rs. 5/- each.	11-Nov-2010
30-May-2010	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, has recommended final dividend @ 40% on the equity share capital of the Company i.e. Rs. 2/- per share subject to approval of members. This is in addition to interim dividend @ 60% on equity share capital of the Company i.e. Rs 3/- per share paid in February 2010.	13-Sep-2010
30-Jan-2010	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2010, inter alia, has approved payment of an Interim Dividend @ 60% i.e. Rs. 3/- (Rupees three only) per Equity Share of Rs. 5/- (Rupees five only) each to the members of the Company for the Current Financial Year 2009-2010.	05-Feb-2010
12-Nov-2009	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2009, inter alia, has considered and approved the following : The final dividend at 30% (Rs. 1.50 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2008-09 has been recommended, subject to approval of members at the ensuing Annual General Meeting to be held on December 23, 2009. The Company in the month of February, 2009 has paid an interim dividend of 60% (Rs. 3.00 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2008-09.	16-Dec-2009
30-Jan-2009	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 30, 2009, inter alia, has approved payment of an Interim Dividend @ 60% i.e., Rs 3/- (Rupees three only) per Equity Share of Rs 5/- (Rupees five only) each to the members of the Company for the Current Financial Year 2008-2009.	05-Feb-2009
18-Jun-2008	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2008, inter alia, has recommended dividend of 65% (Rs 3.25 per share of Rs 5/- each) on its equity share capital of the Company for the year 2007-08 subject to approval of members at the ensuing Annual General Meeting.	11-Aug-2008
30-Jun-2007	D	Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2007, inter alia, has recommended a dividend of 50% (Rs 2.50 per share of Rs 5/- each) on its equity share capital of the Company for the year 2006-07 subject to approval of members in the General Meeting.	14-Sep-2007
02-Jul-2005	D	10% Dividend	20-Sep-2005
10-Jul-2015	B	SUB. :- Bonus issue of Aurobindo Pharma Ltd. (Scrip Code: 524804) Trading Members of the Exchange are hereby informed that, Aurobindo Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Aurobindo Pharma Ltd. (424804; 524804; 624804) RECORD DATE 21/07/2015 PURPOSE Issue of 1 (ONE) Bonus equity share for every 1 (ONE) existing equity share held. Ex-Bonus basis from Date & Sett. No. 20/07/2015 DR-077/2015-2016 Trading Members of the Exchange are requested to take note of it.	21-Jul-2015	1:1
03-Apr-2024	BC	Submission of Postal Ballot Notice for seeking approval of the shareholders to the appointment of Mr. Mangalam Ramasubramanian Kumar as an Independent Director of the Company Submission of notice	07-May-2024
27-Mar-2024	BC	Intimation of changes in Board of Directors of the Company	01-Apr-2024
09-Nov-2023	BC	The Board of Directors of the Company at its meeting held today, November 9, 2023, has inter alia, transacted the following items of business: Approved first interim dividend of 300% i.e., Rs.3.00	31-Mar-2024
10-Feb-2024	BC	Board of Directors in their meeting held today, February 10, 2024, approved the payment of Second Dividend of 150% i.e. Rs.1.50 per shares of Re.1 each.	31-Mar-2024
27-Mar-2024	BC	Intimation of changes in Board of Directors of the Company	31-Mar-2024

Announcement Date10-Feb-2024

Ex Dividend Date20-Feb-2024

Dividend(%)150

Announcement Date09-Nov-2023

Ex Dividend Date20-Nov-2023

Dividend(%)300

Announcement Date09-Feb-2023

Ex Dividend Date17-Feb-2023

Dividend(%)300

Announcement Date30-May-2022

Ex Dividend Date06-Jun-2022

Dividend(%)450

Announcement Date09-Feb-2022

Ex Dividend Date18-Feb-2022

Dividend(%)150

Announcement Date08-Nov-2021

Ex Dividend Date17-Nov-2021

Dividend(%)150

Announcement Date12-Aug-2021

Ex Dividend Date27-Aug-2021

Dividend(%)150

Announcement Date10-Feb-2021

Ex Dividend Date22-Feb-2021

Dividend(%)150

Announcement Date11-Nov-2020

Ex Dividend Date23-Nov-2020

Dividend(%)125

Announcement Date12-Aug-2020

Ex Dividend Date21-Aug-2020

Dividend(%)125

Announcement Date06-Feb-2020

Ex Dividend Date17-Feb-2020

Dividend(%)175

Announcement Date12-Nov-2019

Ex Dividend Date21-Nov-2019

Dividend(%)125

Announcement Date07-Feb-2019

Ex Dividend Date15-Feb-2019

Dividend(%)125

Announcement Date12-Nov-2018

Ex Dividend Date20-Nov-2018

Dividend(%)125

Announcement Date07-Feb-2018

Ex Dividend Date20-Feb-2018

Dividend(%)100

Announcement Date09-Nov-2017

Ex Dividend Date21-Nov-2017

Dividend(%)150

Announcement Date30-May-2017

Ex Dividend Date08-Jun-2017

Dividend(%)125

Announcement Date14-Nov-2016

Ex Dividend Date24-Nov-2016

Dividend(%)125

Announcement Date30-May-2016

Ex Dividend Date09-Jun-2016

Dividend(%)70

Announcement Date09-Feb-2016

Ex Dividend Date18-Feb-2016

Dividend(%)70

Announcement Date06-Nov-2015

Ex Dividend Date19-Nov-2015

Dividend(%)60

Announcement Date12-Aug-2015

Ex Dividend Date21-Aug-2015

Dividend(%)50

Announcement Date28-May-2015

Ex Dividend Date08-Jun-2015

Dividend(%)100

Announcement Date05-Feb-2015

Ex Dividend Date16-Feb-2015

Dividend(%)200

Announcement Date07-Aug-2014

Ex Dividend Date13-Aug-2014

Dividend(%)150

Announcement Date30-May-2014

Ex Dividend Date11-Jun-2014

Dividend(%)175

Announcement Date08-Nov-2013

Ex Dividend Date19-Nov-2013

Dividend(%)125

Announcement Date30-May-2013

Ex Dividend Date30-Jul-2013

Dividend(%)50

Announcement Date07-Feb-2013

Ex Dividend Date18-Feb-2013

Dividend(%)100

Announcement Date30-May-2012

Ex Dividend Date30-Jul-2012

Dividend(%)100

Announcement Date09-May-2011

Ex Dividend Date20-Jul-2011

Dividend(%)100

Announcement Date03-Nov-2010

Ex Dividend Date11-Nov-2010

Dividend(%)100

Announcement Date30-May-2010

Ex Dividend Date13-Sep-2010

Dividend(%)40

Announcement Date30-Jan-2010

Ex Dividend Date05-Feb-2010

Dividend(%)60

Announcement Date12-Nov-2009

Ex Dividend Date16-Dec-2009

Dividend(%)30

Announcement Date30-Jan-2009

Ex Dividend Date05-Feb-2009

Dividend(%)60

Announcement Date18-Jun-2008

Ex Dividend Date11-Aug-2008

Dividend(%)65

Announcement Date30-Jun-2007

Ex Dividend Date14-Sep-2007

Dividend(%)50

Announcement Date02-Jul-2005

Ex Dividend Date20-Sep-2005

Dividend(%)10

No Rights has been declared by AUROPHARMA

Book Closure

Record Date	Split Date	Purpose
07-May-2024	01 Jan'1900	Submission of Postal Ballot Notice for seeking approval of the shareholders to the appointment of Mr. Mangalam Ramasubramanian Kumar as an Independent Director of the Company Submission of notice
01-Apr-2024	-	Intimation of changes in Board of Directors of the Company
31-Mar-2024	-	The Board of Directors of the Company at its meeting held today, November 9, 2023, has inter alia, transacted the following items of business: Approved first interim dividend of 300% i.e., Rs.3.00
31-Mar-2024	-	Board of Directors in their meeting held today, February 10, 2024, approved the payment of Second Dividend of 150% i.e. Rs.1.50 per shares of Re.1 each.
31-Mar-2024	-	Intimation of changes in Board of Directors of the Company

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Aurobindo Pharma Ltd ₹1,151.80(+20.50/1.81%)	1,151.80	+20.50	66,287.23	84.42	33.71	3.55
Lupin Ltd ₹1,637.45(+21.50/1.33%)	1,637.45	+21.50	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,334.00(-4.50/-0.34%)	1,334.00	-4.50	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,906.65(+41.60/2.23%)	1,906.65	+41.60	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,277.50(+3.35/0.04%)	8,277.50	+3.35	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹396.50(-3.00/-0.75%)	396.50	-3.00	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	2663.87	2648.41	2363.53	2371.73	2336.52	1932.82
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2663.87	2648.41	2363.53	2371.73	2336.52	1932.82
Other Operating Income	28.16	20.35	27.29	34.50	24.39	15.39
Other Income	331.13	103.17	112.83	279.96	78.01	55.43
Total Income	3023.16	2771.93	2503.65	2686.19	2438.92	2003.64
Total Expenditure	2210.34	2123.58	1968.44	1830.29	1940.80	1699.64
PBIDT	812.82	648.35	535.21	855.90	498.12	304.00
Interest	61.25	36.69	31.59	31.77	25.26	12.45
PBDT	751.57	611.66	503.62	824.13	472.86	291.55
Depreciation	64.35	65.79	59.63	66.68	59.87	60.70
Tax	136.95	137.17	116.30	115.07	123.36	69.61
Deferred Tax	-73.51	-7.04	-8.26	-2.42	-9.19	-3.39
Reported Profit After Tax	623.78	415.74	335.95	644.80	298.82	164.63
Extra-ordinary Items	0.00	36.09	17.95	0.00	-24.12	-19.68
Adjusted Profit After Extra-ordinary item	623.78	379.65	318.00	644.80	322.94	184.31

EPS (Unit Curr.)	10.65	7.10	5.74	10.22	5.10	2.81
EPS (Adj) (Unit Curr.)	10.65	7.10	5.74	10.22	5.10	2.81
Calculated EPS (Unit Curr.)	10.65	7.10	5.73	11.01	5.10	2.81
Calculated EPS (Adj) (Unit Curr.)	10.65	7.10	5.73	11.01	5.10	2.81
Calculated EPS (Ann.) (Unit Curr.)	42.59	28.38	22.94	44.02	20.40	11.24
Calculated EPS (Adj) (Ann.) (Unit Curr.)	42.59	28.38	22.94	44.02	20.40	11.24
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	150.00	0.00	0.00	0.00	300.00	0.00
Equity	58.59	58.59	58.59	58.59	58.59	58.59
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	30.51	24.48	22.64	36.09	21.32	15.73
PBDTM(%)	28.21	23.10	21.31	34.75	20.24	15.08
PATM(%)	23.42	15.70	14.21	27.19	12.79	8.52

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	7271.23	7150.71	6790.64	6378.67	6387.97	5673.65
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	7271.23	7150.71	6790.64	6378.67	6387.97	5673.65
Other Operating Income	80.55	68.71	59.88	94.29	19.16	65.72
Other Income	162.52	187.88	116.33	134.91	92.65	57.19
Total Income	7514.30	7407.30	6966.85	6607.87	6499.78	5796.56
Total Expenditure	5753.06	5845.98	5771.71	5476.64	5453.31	4949.81
PBIDT	1761.24	1561.32	1195.14	1131.23	1046.47	846.75
Interest	75.55	68.18	56.55	55.60	44.96	25.29
PBDT	1685.69	1493.14	1138.59	1075.63	1001.51	821.46
Depreciation	423.27	417.50	326.56	345.57	321.40	298.10
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	384.60	481.83	340.47	580.39	136.07	165.92
Deferred Tax	-62.15	-158.13	-98.15	-356.24	53.03	-52.93
Reported Profit After Tax	939.97	751.94	569.71	505.91	491.01	410.37
Minority Interest After NP	3.68	-5.24	-1.04	-0.36	-0.25	0.92
Net Profit after Minority Interest	936.29	757.18	570.75	506.27	491.26	409.45

Extra-ordinary Items	0.00	0.00	-40.51	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	936.29	757.18	611.26	506.27	491.26	409.45

EPS (Unit Curr.)	16.04	12.83	9.74	8.64	8.38	6.99
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	150.00	0.00	0.00	0.00	300.00	0.00
Equity	58.59	58.59	58.59	58.59	58.59	58.59

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.22	21.83	17.60	17.73	16.38	14.92
PBDTM(%)	23.18	20.88	16.77	16.86	15.68	14.48
PATM(%)	12.93	10.52	8.39	7.93	7.69	7.23

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	58.59	58.59	58.59	58.59	58.59	58.59
Reserves Total	17855.58	17058.75	15866.02	12993.91	11292.03	9923.99
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	17914.17	17117.34	15924.61	13052.50	11350.62	9982.58
Secured Loans	1922.78	288.75	841.50	1314.36	1594.43	376.19
Unsecured Loans	2280.38	1606.14	3200.46	2427.10	2925.37	3342.81
Total Debt	4203.16	1894.89	4041.96	3741.46	4519.80	3719.00
Total Liabilities	22117.33	19012.23	19966.57	16793.96	15870.42	13701.58
APPLICATION OF FUNDS :
Gross Block	6214.72	5724.90	6688.90	6180.91	5446.15	4292.18
Less : Accumulated Depreciation	2527.22	2139.07	2216.83	1763.11	1296.45	899.21
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	3687.50	3585.83	4472.07	4417.80	4149.70	3392.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	239.09	225.15	734.89	814.85	789.01	1143.98
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	8221.78	6584.36	5009.93	2527.41	2339.06	1967.50
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	4125.26	3356.18	4841.38	4359.57	3971.26	3409.23
Sundry Debtors	4560.26	3973.24	5928.01	5785.00	5232.07	4468.23
Cash and Bank	132.14	50.78	386.18	86.16	75.77	245.90
Loans and Advances	905.97	2454.90	1051.40	1057.55	1129.22	857.82
Total Current Assets	9723.63	9835.10	12206.97	11288.28	10408.32	8981.18
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2391.01	2243.30	2539.03	2526.66	2120.15	1960.64
Provisions	122.09	103.36	250.01	115.27	96.51	74.54
Total Current Liabilities	2513.10	2346.66	2789.04	2641.93	2216.66	2035.18
Net Current Assets	7210.53	7488.44	9417.93	8646.35	8191.66	6946.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	55.24	43.82	68.61	411.92	439.87	382.06
Deferred Tax Liability	271.15	280.85	501.99	496.96	470.87	405.54
Net Deferred Tax	-215.91	-237.03	-433.38	-85.04	-31.00	-23.48
Total Assets	19142.99	17646.75	19201.44	16321.37	15438.43	13426.97
Contingent Liabilities	120.26	152.93	770.10	2006.56	2496.37	1214.54

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	58.59	58.59	58.59	58.59	58.59	58.59
Reserves Total	26781.26	24517.39	21871.28	16766.08	13832.19	11621.83
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	26839.85	24575.98	21929.87	16824.67	13890.78	11680.42
Minority Interest	12.00	-1.93	-0.88	0.14	1.59	1.82
Secured Loans	2557.37	543.69	1053.55	1314.97	1661.87	419.18
Unsecured Loans	2728.84	2307.58	4285.53	4511.41	5304.89	4350.75
Total Debt	5286.21	2851.27	5339.08	5826.38	6966.76	4769.93
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	214.26	212.91	250.71	162.19	80.16	66.43
Total Liabilities	32352.32	27638.23	27518.78	22813.38	20939.29	16518.60
APPLICATION OF FUNDS :
Gross Block	18143.23	15524.55	13613.33	12441.26	10497.62	7894.78
Less: Accumulated Depreciation	7119.54	4992.46	4239.75	3044.79	2022.77	1374.10
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	11023.69	10532.09	9373.58	9396.47	8474.85	6520.68
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	5390.01	3747.20	3061.53	1985.92	1668.46	1583.04
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	542.74	997.15	591.01	554.71	360.22	311.54
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8516.11	7559.08	9041.18	7699.87	7245.60	5858.41
Sundry Debtors	4466.38	4012.26	3503.28	4315.16	3413.78	3080.20
Cash and Bank	6084.20	4190.01	5474.28	2842.15	1957.18	1262.25
Loans and Advances	2332.86	1987.72	1659.59	1555.31	2715.72	1977.28
Total Current Assets	21399.55	17749.07	19678.33	16412.49	15332.28	12178.14
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	6735.93	5643.94	5378.37	5310.95	4849.09	4052.93
Provisions	417.01	233.82	396.89	511.72	384.67	294.23
Total Current Liabilities	7152.94	5877.76	5775.26	5822.67	5233.76	4347.16
Net Current Assets	14246.61	11871.31	13903.07	10589.82	10098.52	7830.98
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	768.88	429.74	600.91	163.20	183.29	539.17
Deferred Tax Liability	481.00	552.11	722.79	291.69	281.31	615.65
Net Deferred Tax	287.88	-122.37	-121.88	-128.49	-98.02	-76.48
Other Assets	861.39	612.85	711.47	414.95	435.26	348.84
Total Assets
Contingent Liabilities	158.53	157.74	140.83	145.98	133.71	211.79

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	48.21	383.58	67.35	68.70	239.95
Net Cash from Operating Activities	1821.16	3726.71	2994.53	2201.38	529.89
Net Cash Used In Investing Activities	-3459.20	-1614.54	-2650.24	-948.08	-1300.54
Net Cash Used In Financing Activities	1719.48	-2447.54	-28.06	-1254.65	599.40
Net Inc./Dec In Cash And Cash Equivalents	81.44	-335.37	316.23	-1.35	-171.25
Cash And Cash Equivalents At End Of The Year	129.65	48.21	383.58	67.35	68.70

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

51.83%

FII Shareholding

18.02%

DII Shareholding

23.28%

Public Shareholding

6.87%

**Promoter pledged shareholding 51.83%

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 66278.45 crores. It has reported a sales of Rs. 2663.87 crores and a net profit of Rs. 623.78 crores for the quarter ended December 2018. The company management includes K Ragunathan, K Ragunathan,Kambam Nityananda Reddy,M Sivakumaran,M Madan Mohan Reddy,P V Ramprasad Reddy,Savita Mahajan,Girish Paman Vanvari,P Sarath Chandra Reddy,Santanu Mukherjee,Deepali Pant Joshi (Aurobindo Pharma Ltd) among others.

Chairman

K Ragunathan

Registered office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad,Telangana,500038

FAX :91-40-23747340

Background

Incorporation Year1986

Face Value₹1

Market Lot1

How to buy Aurobindo Pharma shares on nse?

To buy Aurobindo Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Aurobindo Pharma share price today?

The Aurobindo Pharma shares price on nse is Rs.1151.8 today.

What is the market cap of Aurobindo Pharma shares on NSE ?

The company has a market capitalization of Rs.66287.23Cr

What is the PE & PB ratio of Aurobindo Pharma shares ?

PE is 33.71 and PB is 3.55

What is the 52 Week High and Low of Aurobindo Pharma shares?

Aurobindo Pharma stock price high: Rs.1177.1 Aurobindo Pharma stock price low: Rs.581.25

How can I sell Aurobindo Pharma stocks?

If you hold Aurobindo Pharma stock, you can sell shares by signing up with a brokerage like Motilal Oswal. Initially, you must have a Demat account linked with a trading account. Then you can buy and sell your shares with ease on the stock exchanges via access through Motilal Oswal.

What is the ROI of Aurobindo Pharma stocks?

The ROI of the stocks of Aurobindo Pharma, over five years, is in the negative. The ROI is -16.21 (NSE).

Can I buy Aurobindo Pharma shares now?

You can buy Aurobindo Pharma shares if you sign up with a reputed brokerage like Motilal Oswal, open a Demat account and link it to a trading account.

How has the Aurobindo Pharma stock price performed last year?

The performance of the Aurobindo Pharma stock in the last year has been disappointing with the stock price down by 24%.

What is the trending volume of Aurobindo Pharma stocks?

The trending volume of Aurobindo Pharma stocks as of 3 April 2023 was 2,011,656.